The Bi-directional Effects of Gender-Affirming Hormone Therapy and Preexposure Prophylaxis in Transgender Individuals
Transgender individuals both on and off GAHT had similar PrEP concentrations after 12 weeks of daily oral FTC/TDF PrEP use. Hormone concentrations were not statistically different with or without FTC/TDF PrEP use, and there were no changes in the perceived effect on GAHT in those taking PrEP.
Authors
- Katya Corado (ORCID: https://orcid.org/0000-0003-2063-7925)
- Richard Haubrich (ORCID: https://orcid.org/0000-0002-9435-2386)
- Robert Bolan (ORCID: https://orcid.org/0000-0002-6686-1052)
- Leah Burke (ORCID: https://orcid.org/0000-0001-8220-3263)
- David J. Moore (ORCID: https://orcid.org/0000-0001-9699-318X)
- Jill S. Blumenthal (ORCID: https://orcid.org/0000-0002-2307-9108)
- Michael P. Dubé (ORCID: https://orcid.org/0000-0001-6155-1023)
- Anna K. Mischel (ORCID: https://orcid.org/0000-0001-7433-9355)
- Peter L. Anderson (ORCID: https://orcid.org/0000-0002-1200-8494)
- Sheldon Morris
- Martin Hoenigl (ORCID: https://orcid.org/0000-0002-1653-2824)
- Jordan Silva
- Sara Gianella (ORCID: https://orcid.org/0000-0002-9927-0849)
- Karen Chow (ORCID: https://orcid.org/0000-0001-8027-3233)
- Ravi Goyal (ORCID: https://orcid.org/0000-0002-0358-2435)
Institutions
- University of Southern California (US)
- Medical University of Graz (AT)
- UCLA Medical Center (US)
- Los Angeles LGBT Center (US)
- University of California San Diego (US)
- Gilead Sciences (United States) (US)
- Harbor–UCLA Medical Center (US)
- University of Colorado Anschutz Medical Campus (US)
Publication Details
- Journal
- Open Forum Infectious Diseases
- Published
- 2026-10-26
- DOI
- https://doi.org/10.1093/ofid/ofag628
- Primary Topic
- HIV/AIDS Research and Interventions
- Type
- article
- Field-Weighted Citation Impact
- 0.00